Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy

被引:28
作者
Mutlak, Michael [1 ,2 ]
Schlesinger-Laufer, Michal [3 ]
Haas, Tali [3 ]
Shofti, Rona [3 ]
Ballan, Nimer [1 ,2 ]
Lewis, Yair E. [1 ,2 ]
Zuler, Mor [1 ,2 ]
Zohar, Yaniv [4 ]
Caspi, Lilac H. [1 ,2 ]
Kehat, Izhak [1 ,2 ,5 ,6 ]
机构
[1] Technion Israel Inst Technol, Rappaport Inst, Efron St 6,POB 9649, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Efron St 6,POB 9649, IL-31096 Haifa, Israel
[3] Technion Israel Inst Technol, Preclin Res Author Unit, Haifa, Israel
[4] Rambam Med Ctr, Dept Pathol, IL-31096 Haifa, Israel
[5] Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel
[6] Rambam Med Ctr, Clin Res Inst Rambam, IL-31096 Haifa, Israel
基金
以色列科学基金会;
关键词
Extracellular signal-regulated kinase (ERK); Cardiac hypertrophy; Mitogen-activated protein kinases (MAPKs); Contractile function; LEFT-VENTRICULAR MASS; TRANSCRIPTION FACTOR GATA4; GOOD THERAPEUTIC STRATEGY; HEART-FAILURE; PROTEIN-KINASE; IN-VIVO; PHOSPHORYLATION; PATHWAYS; TARGETS; LOOP;
D O I
10.1016/j.ijcard.2018.05.068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic pressure overload and a variety of mediators induce concentric cardiac hypertrophy. When prolonged, cardiac hypertrophy culminates in decreasedmyocardial function and heart failure. Activation of the extracellular signal-regulated kinase (ERK) is consistently observed in animal models of hypertrophy and in human patients, but its role in the process is controversial. Methods: We generated transgenicmouse lines with cardiomyocyte restricted overexpression of intrinsically active ERK1, which similar to the observations in hypertrophy is phosphorylated on both the TEY and the Thr207 motifs and is overexpressed at pathophysiological levels. Results: The activated ERK1 transgenic mice developed amodest adaptive hypertrophywith increased contractile function and without fibrosis. Following induction of pressure-overload, where multiple pathways are stimulated, this activation did not further increase the degree of hypertrophy but protected the heart through a decrease in the degree of fibrosis and maintenance of ventricular contractile function. Conclusions: The ERK pathway acts to promote a compensated hypertrophic response, with enhanced contractile function and reduced fibrosis. The activation of this pathway may be a therapeutic strategy to preserve contractile function when the pressure overload cannot be easily alleviated. The inhibition of this pathway, which is increasingly being used for cancer therapy on the other hand, should be used with caution in the presence of pressure-overload. (c) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:204 / 213
页数:10
相关论文
共 48 条
  • [1] PHOSPHORYLATION MODULATES CATALYTIC FUNCTION AND REGULATION IN THE CAMP-DEPENDENT PROTEIN-KINASE
    ADAMS, JA
    MCGLONE, ML
    GIBSON, R
    TAYLOR, SS
    [J]. BIOCHEMISTRY, 1995, 34 (08) : 2447 - 2454
  • [2] Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
    Bernardo, Bianca C.
    Weeks, Kate L.
    Pretorius, Lynette
    McMullen, Julie R.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2010, 128 (01) : 191 - 227
  • [3] Analyzing ERK 1/2 signalling and targets
    Brietz, Alexandra
    Schuch, Kristin Verena
    Wangorsch, Gaby
    Lorenz, Kristina
    Dandekar, Thomas
    [J]. MOLECULAR BIOSYSTEMS, 2016, 12 (08) : 2436 - 2446
  • [4] Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death
    Bueno, OF
    Molkentin, JD
    [J]. CIRCULATION RESEARCH, 2002, 91 (09) : 776 - 781
  • [5] The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
    Bueno, OF
    De Windt, LJ
    Tymitz, KM
    Witt, SA
    Kimball, TR
    Klevitsky, R
    Hewett, TE
    Jones, SP
    Lefer, DJ
    Peng, CF
    Kitsis, RN
    Molkentin, JD
    [J]. EMBO JOURNAL, 2000, 19 (23) : 6341 - 6350
  • [6] CellProfiler: image analysis software for identifying and quantifying cell phenotypes
    Carpenter, Anne E.
    Jones, Thouis Ray
    Lamprecht, Michael R.
    Clarke, Colin
    Kang, In Han
    Friman, Ola
    Guertin, David A.
    Chang, Joo Han
    Lindquist, Robert A.
    Moffat, Jason
    Golland, Polina
    Sabatini, David M.
    [J]. GENOME BIOLOGY, 2006, 7 (10)
  • [7] Condorelli Gianluigi, 2008, Heart Fail Monit, V5, P112
  • [8] Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions
    Courcelles, Mathieu
    Fremin, Christophe
    Voisin, Laure
    Lemieux, Sebastien
    Meloche, Sylvain
    Thibault, Pierre
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2013, 9
  • [9] Inhibition of Hypertrophy, Per Se, May Not Be a Good Therapeutic Strategy in Ventricular Pressure Overload: Other Approaches Could Be More Beneficial
    Crozatier, Bertrand
    Ventura-Clapier, Renee
    [J]. CIRCULATION, 2015, 131 (16) : 1448 - 1457
  • [10] ERBB2 triggers mammalian heart regeneration by promoting cardiorlyocyte dedifferentiation and proliferation
    D'Uva, Gabriele
    Aharonov, Alla
    Lauriola, Mattia
    Kain, David
    Yahalom-Ronen, Yfat
    Carvalho, Silvia
    Weisinger, Karen
    Bassat, Elad
    Rajchman, Dana
    Yifa, Oren
    Lysenko, Marina
    Konfino, Tal
    Hegesh, Julius
    Brenner, Ori
    Neeman, Michal
    Yarden, Yosef
    Leor, Jonathan
    Sarig, Rachel
    Harvey, Richard P.
    Tzahor, Eldad
    [J]. NATURE CELL BIOLOGY, 2015, 17 (05) : 627 - U207